跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DHAMOL SUSPENSION 250 mg/5 ml - HSA Drug Approval Details
Approvals
/
HSA
/
DHAMOL SUSPENSION 250 mg/5 ml
Approved
THERAPEUTIC
DHAMOL SUSPENSION 250 mg/5 ml
PT ACTAVIS INDONESIA
🇸🇬 Health Sciences Authority
Approval Date
Jul 3, 1991
Approval ID
f10210acf74e6b03
Company
PT ACTAVIS INDONESIA
Type
Therapeutic
Approval Details
Approval Id
f10210acf74e6b03
Drug Name
DHAMOL SUSPENSION 250 mg/5 ml
Product Name
DHAMOL SUSPENSION 250 mg/5 ml
Approval Number
SIN06364P
Approval Date
1991-07-03
Registrant
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence Holder
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
General Sale List
Dosage Form
SUSPENSION
Route Of Administration
ORAL
Atc Code
N02BE01
Atc Item Name
paracetamol
Pharma Manufacturer Name
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Company Detail Path
/organization/teva-pharmaceutical-investments-singapore-pte-ltd
Active Ingredients
PARACETAMOL
250 mg/5 ml
PARACETAMOL
250 MG/5 ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jul 3, 1991
Approval ID
f10210acf74e6b03
Type
Therapeutic
Back to HSA Approvals